Buying This Stock Could Give You Exposure to SpaceX Before Its IPO. Should You Do It?

SpaceX is expected to go public as early as this summer at a valuation approaching $2 trillion, but the article argues investors should not buy EchoStar solely for indirect exposure. EchoStar received $11.1 billion of SpaceX stock in last year’s spectrum deal, now estimated at about $28 billion, but the company is burdened by high debt, two straight years of operating losses, and declining sales. The piece frames the setup as speculative rather than a clear near-term catalyst for EchoStar shares.

Analysis

SATS is effectively trading as a leveraged call on a private asset whose mark will be reset only at the IPO, but the market is likely overstating how much of that optionality actually flows through to equity holders. The cleaner read is that the SpaceX stake creates balance-sheet narrative support, yet the operating business still drags the equity through debt, negative earnings power, and declining core revenue. In other words, any upside from the private-markup is likely to be diluted by the market applying a higher discount rate to the remaining business rather than capitalizing the SpaceX mark at face value.

The second-order winner is not necessarily EchoStar, but the adjacent public-market “proxy” complex: anything perceived as a cheaper, more liquid way to express space/low-earth-orbit exposure could see brief momentum inflows into the IPO window. That said, a $2T valuation path increases the odds that the first trade in SpaceX is more about scarcity and index/chatter demand than fundamental anchoring, which can produce a post-deal air pocket if lockup or secondary supply expectations build faster than fundamental buyers.

The key catalyst sequence is months, not days: IPO pricing, first-quarter post-listing performance, and any indication of whether the company uses the public print to broaden financing or simply monetize existing holders. The main contrarian miss is that investors may assume EchoStar’s stake behaves like a liquid, mark-to-market treasury asset; in practice, the market will likely haircut it for transferability, concentration, and volatility, so the equity may not re-rate as much as headline arithmetic suggests unless the core telecom business stabilizes. On the downside, any weak IPO tape would hurt SATS twice—by reducing perceived embedded value and by reinforcing the market’s skepticism about management’s capital allocation choices.

Key Decisions for Investors

• Avoid chasing SATS for indirect SpaceX exposure over the next 1-3 months; the risk/reward is poor because the embedded private-asset upside is likely more than offset by core-business deterioration and balance-sheet leverage.
• If already long SATS, reduce into any pre-IPO strength and consider replacing exposure with a defined-risk upside vehicle on the IPO itself rather than holding the operating company as a proxy.
• Watch for a post-IPO dislocation in SpaceX if it lists at a very rich multiple and opens weak; that is the cleaner long entry versus buying SATS, with a better asymmetry if the first 4-8 weeks are volatile.
• Relative-value idea: short SATS vs long a basket of higher-quality telecom/satellite peers to isolate the overvalued optionality premium from the weak operating business over 3-6 months.
• If SpaceX debuts strongly and SATS fails to re-rate, use that divergence to fade the proxy trade; the market will be signaling that the SpaceX stake is being heavily discounted inside SATS.